Vanda Pharmaceuticals
VNDA
#8239
Rank
NZ$0.53 B
Marketcap
NZ$8.95
Share price
-3.36%
Change (1 day)
13.61%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Total assets

Total assets on the balance sheet as of March 2026 : NZ$0.74 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's total assets are NZ$0.74 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Vanda Pharmaceuticals - Total assets on balance sheet (from 2005 to 2026)

Total assets by year

Year Total assets Change
2025-12-31NZ$0.84 B-27.44%
2024-12-31NZ$1.16 B13.48%
2023-12-31NZ$1.02 B2.64%
2022-12-31NZ$0.99 B14.91%
2021-12-31NZ$0.86 B17.58%
2020-12-31NZ$0.73 B2.93%
2019-12-31NZ$0.71 B45.06%
2018-12-31NZ$0.49 B71.18%
2017-12-31NZ$0.28 B-4.76%
2016-12-31NZ$0.30 B-2.44%
2015-12-31NZ$0.31 B42.05%
2014-12-31NZ$0.21 B25.63%
2013-12-31NZ$0.17 B5.95%
2012-12-31NZ$0.16 B-29.63%
2011-12-31NZ$0.23 B-15.29%
2010-12-31NZ$0.27 B-11.12%
2009-12-31NZ$0.31 B261.16%
2008-12-31NZ$86.04 M-31.95%
2007-12-31NZ$0.12 B145.68%
2006-12-31NZ$51.46 M-1.6%
2005-12-31NZ$52.3 M110.25%
2004-12-31NZ$24.87 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
NZ$347.02 B 46,239.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$204.75 B 27,241.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$358.63 B 47,790.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$201.37 B 26,790.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$222.29 B 29,583.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$149.37 B 19,847.18%๐Ÿ‡บ๐Ÿ‡ธ USA